3135 results for «291»

Filter By

3135 results

Hot topics in TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest hot topics in TAVI, including the impact of balloon-expandable TAVR valve deformation and calcium distribution on outcomes in bicuspid aortic valve, the outcomes of complex and high-risk vs. standard PCI in TAVI patients, hemodynamic outcomes after TAVI for aortic stenosis with small annuli,...

Hot topics in TAVI

LAA closure procedure step-by-step

09 Feb 2025 – From PCR Tokyo Valves 2025

Want to master the step-by-step approach to Left Atrial Appendage Closure (LAAC)? This session is for you!

Follow expert operators as they walk you through the entire procedure, from pre-procedural imaging with TEE and CT to intracardiac echocardiography guidance and precise device deployment. Learn how to assess...

LAA closure procedure step by step

Combined valve disease

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...

Combined valve disease

Imaging aortic valve

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore cutting-edge imaging techniques to assess and guide the management of aortic valve disease in this comprehensive session. From preprocedural assessment with TEE to advanced CT and MRI strategies, learn how to evaluate and treat patients with low-flow low-gradient aortic stenosis, aortic regurgitation, and post-TAVI complications....

Imaging aortic valve

PCR Tokyo Valves 2025 Closing Ceremony

09 Feb 2025 – From PCR Tokyo Valves 2025

Join us for the powerful closing ceremony of PCR Tokyo Valves 2025, following a course that gathered 1,200 participants. Watch the winner of the best clinical case present his complex case of severe aortic stenosis, left main coronary artery dissection, and severe primary mitral regurgitation in...

PCR Tokyo Valves 2025 Closing Ceremony

PCR Tokyo Valves 2025 Welcome Ceremony

08 Feb 2025 – From PCR Tokyo Valves 2025

Relive the 10th PCR Tokyo Valves Opening Ceremony, starting with a heartfelt tribute to Kentaro Hayashida and Shigeru Saito, the visionaries behind this enduring Course. Look back on a decade of growth, meet past directors, and hear inspiring testimonials from key contributors and participants. Finally, enjoy...

PCR Tokyo Valves 2025 Welcome Ceremony

TAVI in challenging anatomy

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...

TAVI in challenging anatomy

More possibilities in TEER - Treatment of degenerative mitral regurgitation

09 Feb 2025 – From PCR Tokyo Valves 2025

Through case reviews, explore the latest advancements in transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation. Discover how a novel TEER device expands treatment possibilities, offering predictable and durable results.

More possibilities in TEER - Treatment of degenerative mitral regurgitation

TAVI abstracts

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the latest TAVI-related research and advancements. Explore studies on optimizing hemostasis during TAVI, the safety and efficacy of TAVI in Filipino patients, the outcomes of TAVI in hemodialysis patients, and the effectiveness of patient education videos for TAVI. Stay up-to-date with the latest developments...

TAVI abstracts

LAA closure

09 Feb 2025 – From PCR Tokyo Valves 2025

This session offers valuable insights into various aspects of left atrial appendage (LAA) closure, a critical procedure for stroke prevention in atrial fibrillation patients. Explore improvements to the safety checklist, case studies on left atrial thrombosis and mobile thrombus management, as well as a successful case...

LAA closure

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)

07 Nov 2024

Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author

Aaysha Cader
Comparison of puncture success rate between distal radial access and transradial access in patients with STEMI (DRAMI)

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?